MCHP
59
4
ECL
50
-2
MNST
50
-2
PM
77
-2
MUR
36
2
BAC
54
-3
CTAS
59
-5
ILMN
49
3
AFL
39
-3
SYY
60
2
WDC
68
4
SBUX
52
4
BAX
53
5
TRIP
40
2
CB
48
-3
NWL
43
2
CME
43
-2
NFLX
74
-2
NTAP
67
-4
EQT
45
-6
MCHP
59
4
ECL
50
-2
MNST
50
-2
PM
77
-2
MUR
36
2
BAC
54
-3
CTAS
59
-5
ILMN
49
3
AFL
39
-3
SYY
60
2
WDC
68
4
SBUX
52
4
BAX
53
5
TRIP
40
2
CB
48
-3
NWL
43
2
CME
43
-2
NFLX
74
-2
NTAP
67
-4
EQT
45
-6
Financhill
Back

Kura Oncology 10K Form

Sell
35

KURA
Kura Oncology

Last Price:
$6.74
Seasonality Move:
5.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KURA News And Ratings

See the #1 stock for the next 7 days that we like better than KURA

KURA Financial Statistics

Sales & Book Value

Annual Sales: $53.9M
Cash Flow: $-72.2M
Price / Cash Flow: 5.3
Annual Sales: $4.51
Price / Book: 1.6

Profitability

EPS (TTM): -2.10000
Net Income (TTM): $-181.9M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Kura Oncology Earnings Forecast

Key Kura Oncology Financial Ratios

  • The Selling, General & Administrative Expenses for KURA have been equal to 143.11% of Gross Profit Margin.
  • The Research & Development expenses have been 315.44% of Revenue.
  • The Net Earning history of KURA is -322.89% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 3 years.

Kura Oncology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KURA
CUSIP: 50127T
Website: kuraoncology.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 8.07
Quick Ratio: 7.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KURA Technical Analysis vs Fundamental Analysis

Sell
35
Kura Oncology (KURA) is a Sell

Is Kura Oncology a Buy or a Sell?

  • Kura Oncology stock is rated a Sell
    The current Kura Oncology [KURA] share price is $6.73. The Score for KURA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.